Form 4: Enovix Director Betsy S. Atkins Sells 75,000 Shares Under 10b5-1 Trading Plan

Director Betsy S. Atkins sold 75,000 shares of Enovix Corp common stock at a weighted average price of $9.73 per share, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Betsy S. Atkins, a director at Enovix Corp, sold 75,000 shares of common stock on December 3, 2024.
• The sale was executed under a Rule 10b5-1 trading plan adopted on August 29, 2023.
• The shares were sold at a weighted-average price of $9.73, with individual transactions ranging from $9.54 to $10.02.
• Following the transaction, Atkins beneficially owns 99,497 shares, which includes 11,346 shares issuable upon the settlement of restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to insider trading. It does not indicate any positive or negative sentiment about the company's performance or future prospects.

Risks

• Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with regulatory requirements.
• The use of a 10b5-1 trading plan is a common method for insiders to sell shares while avoiding accusations of trading on non-public information.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment.

Key Dates

Keywords

Enovix, ENVX, insider trading, Form 4, stock sale, Rule 10b5-1, Betsy S. Atkins, director, equity securities